A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832)

Auckland Clinical Studies, Auckland

Instituto Neurologia Bs As, Ciudad Autonoma de Bs As

Wellington Hospital Research Office, Wellington

University of Otago; Psychological Medicine Department, Dunedin

UVaMID Hospital Santa Caterina;; Servicio de Neurología, Salt

Clínica Para la Atención del Neurodesarrollo, Aguascalientes

Johns Hopkins Hospital., Baltimore

Duke Clin Rsch Institute, Durham

Hospital Universitario de la Princesa; Medicina Interna, Madrid

Emory University School of Medicine; Department of Human Genetics & Pediatrics, Decatur

Hospital Dr. Angel Leaño; Pediatria, Guadalajara

University of Wisconsin Madison, Waisman Center, Madison

Rush University Medical Center, Chicago

Hospital Médica Tec 100, Querétaro

University of Utah School of Medicine; Department of Pediatrics, Salt Lake City

Univ of CA San Diego; Neurosciences Comp.Alzheimer's, La Jolla

KK Women's and Children's Hospital; Department of Neonatology, Singapore

Massachusette General Hospital; Medical Genetics, Boston

UT Southwestern Medical Center, Dallas

Instituto de Investigaciones Neurologicas Raul Carrea FLENI, Capital Federal

True North Clinical Research Kentville, Kentville

IMIM, Human Pharmacology and Clinical Neurosciences,, Barcelona